Vanguard Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding LHDX
EV
RA
CS
Vanguard Group's LHDX Position: Q1 2023 in Review
Vanguard Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 623,488 shares — an estimated $69.3K sold.
Vanguard Group first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $7.68M in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.
- Vanguard Group reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Vanguard Group sold 623,488 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $69.3K.
- Vanguard Group first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
- Vanguard Group's Lucira Health, Inc. Common Stock position peaked at $7.68M in Q1 2021.
- 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.
Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.